| Pharmaceutical active ingredients: |
| Naphazoline HydrochloridePheniramine Maleate |
| Available forms, composition and doses of Mirus: |
| N / A |
| Mirus medical category: |
| Human:Ophthalmic decongestants, anesthetics, anti-inflammatoriesVasoconstrictors |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| S01GA51 - Naphazoline, combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Alcon |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Irazol | Naphazoline Hydrochloride; Pheniramine Maleate | Ashford Pharmaceutical Laboratories; Medilife Pharma |
| Isotic Azora | Naphazoline Hydrochloride; Pheniramine Maleate | Fahrenheit |
| Konjunktival | Naphazoline Hydrochloride; Pheniramine Maleate | Alcon |
| Konjunktival Thilo | Naphazoline Hydrochloride; Pheniramine Maleate | Alcon; DKSH; Firma Chun Cheong |
| Miral | Naphazoline Hydrochloride; Pheniramine Maleate | Chile Laboratorios |
| Nafazair A | Naphazoline Hydrochloride; Pheniramine Maleate | Bausch and Lomb |
| Nafcon A | Naphazoline Hydrochloride; Pheniramine Maleate | Alcon |
| Naphazole-A | Naphazoline Hydrochloride; Pheniramine Maleate | The Harvard Drug Group |
| Naphazoline Plus | Naphazoline Hydrochloride; Pheniramine Maleate | Parmed Pharmaceuticals |
| Naphazoline; Pheniramine | Naphazoline Hydrochloride; Pheniramine Maleate | Altaire Pharmaceuticals |